{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:03:31Z","timestamp":1792047811275,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-51745-4","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T18:03:50Z","timestamp":1726509830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["A single-domain antibody targeting factor XII inhibits both thrombosis and inflammation"],"prefix":"10.1038","volume":"15","author":[{"given":"Pengfei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Konrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5837-1926","authenticated-orcid":false,"given":"Zhao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1116-4559","authenticated-orcid":false,"given":"Jianwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3848-7251","authenticated-orcid":false,"given":"Nailin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2636-4297","authenticated-orcid":false,"given":"De-Pei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Renn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0532-6312","authenticated-orcid":false,"given":"Miao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"51745_CR1","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1182\/blood-2017-04-569111","volume":"131","author":"C Maas","year":"2018","unstructured":"Maas, C. & Renn\u00e9, T. Coagulation factor XII in thrombosis and inflammation. Blood 131, 1903\u20131909 (2018).","journal-title":"Blood"},{"key":"51745_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.thromres.2009.11.028","volume":"125","author":"E Stavrou","year":"2010","unstructured":"Stavrou, E. & Schmaier, A. H. Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis. Thromb. Res. 125, 210\u2013215 (2010).","journal-title":"Thromb. Res."},{"key":"51745_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1084\/jem.20050664","volume":"202","author":"T Renn\u00e9","year":"2005","unstructured":"Renn\u00e9, T. et al. Defective thrombus formation in mice lacking coagulation factor XII. J. Exp. Med. 202, 271\u2013281 (2005).","journal-title":"J. Exp. Med."},{"key":"51745_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1084\/jem.20052458","volume":"203","author":"C Kleinschnitz","year":"2006","unstructured":"Kleinschnitz, C. et al. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J. Exp. Med. 203, 513\u2013518 (2006).","journal-title":"J. Exp. Med."},{"key":"51745_CR5","doi-asserted-by":"publisher","first-page":"222ra217","DOI":"10.1126\/scitranslmed.3006804","volume":"6","author":"M Larsson","year":"2014","unstructured":"Larsson, M. et al. A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk. Sci. Transl. Med. 6, 222ra217 (2014).","journal-title":"Sci. Transl. Med."},{"key":"51745_CR6","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1182\/blood-2013-04-499111","volume":"123","author":"A Matafonov","year":"2014","unstructured":"Matafonov, A. et al. Factor XII inhibition reduces thrombus formation in a primate thrombosis model. Blood 123, 1739\u20131746 (2014).","journal-title":"Blood"},{"key":"51745_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/rth2.12309","volume":"4","author":"M Wallisch","year":"2020","unstructured":"Wallisch, M. et al. Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primates. Res. Pr. Thromb. Haemost. 4, 205\u2013216 (2020).","journal-title":"Res. Pr. Thromb. Haemost."},{"key":"51745_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17648-w","volume":"11","author":"J Wilbs","year":"2020","unstructured":"Wilbs, J. et al. Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs. Nat. Commun. 11, 3890 (2020).","journal-title":"Nat. Commun."},{"key":"51745_CR9","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/j.jacc.2019.08.1028","volume":"74","author":"V Pireaux","year":"2019","unstructured":"Pireaux, V. et al. Anticoagulation With an Inhibitor of Factors XIa and XIIa During Cardiopulmonary Bypass. J. Am. Coll. Cardiol. 74, 2178\u20132189 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"51745_CR10","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1182\/blood-2013-12-540872","volume":"123","author":"JW Yau","year":"2014","unstructured":"Yau, J. W. et al. Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits. Blood 123, 2102\u20132107 (2014).","journal-title":"Blood"},{"key":"51745_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1182\/blood-2016-09-692996","volume":"129","author":"JC Fredenburgh","year":"2017","unstructured":"Fredenburgh, J. C., Gross, P. L. & Weitz, J. I. Emerging anticoagulant strategies. Blood 129, 147\u2013154 (2017).","journal-title":"Blood"},{"key":"51745_CR12","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1172\/JCI77139","volume":"125","author":"J Bjorkqvist","year":"2015","unstructured":"Bjorkqvist, J. et al. Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III. J. Clin. Invest. 125, 3132\u20133146 (2015).","journal-title":"J. Clin. Invest."},{"key":"51745_CR13","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1172\/JCI92880","volume":"128","author":"EX Stavrou","year":"2018","unstructured":"Stavrou, E. X. et al. Factor XII and uPAR upregulate neutrophil functions to influence wound healing. J. Clin. Invest. 128, 944\u2013959 (2018).","journal-title":"J. Clin. Invest."},{"key":"51745_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11626","volume":"7","author":"K Gobel","year":"2016","unstructured":"Gobel, K. et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat. Commun. 7, 11626 (2016).","journal-title":"Nat. Commun."},{"key":"51745_CR15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/363446a0","volume":"363","author":"C Hamers-Casterman","year":"1993","unstructured":"Hamers-Casterman, C. et al. Naturally occurring antibodies devoid of light chains. Nature 363, 446\u2013448 (1993).","journal-title":"Nature"},{"key":"51745_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pharmthera.2016.06.012","volume":"169","author":"G Van Heeke","year":"2017","unstructured":"Van Heeke, G. et al. Nanobodies\u00ae as inhaled biotherapeutics for lung diseases. Pharmacol. Therapeutics 169, 47\u201356 (2017).","journal-title":"Pharmacol. Therapeutics"},{"key":"51745_CR17","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1111\/febs.15515","volume":"288","author":"S Muyldermans","year":"2021","unstructured":"Muyldermans, S. A guide to: generation and design of nanobodies. FEBS J. 288, 2084\u20132102 (2021).","journal-title":"FEBS J."},{"key":"51745_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.sbi.2020.01.003","volume":"60","author":"T Ucha\u0144ski","year":"2020","unstructured":"Ucha\u0144ski, T., Pardon, E. & Steyaert, J. Nanobodies to study protein conformational states. Curr. Opin. Struct. Biol. 60, 117\u2013123 (2020).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"51745_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1182\/blood.2019000954","volume":"134","author":"MA Mazepa","year":"2019","unstructured":"Mazepa, M. A., Masias, C. & Chaturvedi, S. How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknowns. Blood 134, 415\u2013420 (2019).","journal-title":"Blood"},{"key":"51745_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25888-7","volume":"12","author":"M Heestermans","year":"2021","unstructured":"Heestermans, M. et al. Identification of the factor XII contact activation site enables sensitive coagulation diagnostics. Nat. Commun. 12, 5596 (2021).","journal-title":"Nat. Commun."},{"key":"51745_CR21","doi-asserted-by":"crossref","unstructured":"Zhang, Y. et al. Factor XII and prekallikrein promote microvascular inflammation and psoriasis in mice. Br. J. Pharmacol. (2024). doi: 10.1111\/bph.16428.","DOI":"10.1111\/bph.16428"},{"key":"51745_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/rth2.12346","volume":"4","author":"J Sniderman","year":"2020","unstructured":"Sniderman, J., Monagle, P., Annich, G. M. & MacLaren, G. Hematologic concerns in extracorporeal membrane oxygenation. Res. Pr. Thromb. Haemost. 4, 455\u2013468 (2020).","journal-title":"Res. Pr. Thromb. Haemost."},{"key":"51745_CR23","doi-asserted-by":"publisher","first-page":"e400","DOI":"10.1097\/CCM.0000000000004286","volume":"48","author":"T Granja","year":"2020","unstructured":"Granja, T. et al. Multi-Modal Characterization of the Coagulopathy Associated With Extracorporeal Membrane Oxygenation. Crit. Care Med. 48, e400\u2013e408 (2020).","journal-title":"Crit. Care Med."},{"key":"51745_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1570-4","volume":"20","author":"JE Millar","year":"2016","unstructured":"Millar, J. E., Fanning, J. P., McDonald, C. I., McAuley, D. F. & Fraser, J. F. The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit. Care 20, 387 (2016).","journal-title":"Crit. Care"},{"key":"51745_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2165\/00128071-200809020-00001","volume":"9","author":"KR Chen","year":"2008","unstructured":"Chen, K. R. & Carlson, J. A. Clinical approach to cutaneous vasculitis. Am. J. Clin. Dermatol. 9, 71\u201392 (2008).","journal-title":"Am. J. Clin. Dermatol."},{"key":"51745_CR26","doi-asserted-by":"crossref","unstructured":"Shochet, L., Holdsworth, S. & Kitching, A. R. Animal Models of ANCA Associated Vasculitis. Front. Immunol. 11, 525 (2020).","DOI":"10.3389\/fimmu.2020.00525"},{"key":"51745_CR27","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1073\/pnas.0507195103","volume":"103","author":"SA Smith","year":"2006","unstructured":"Smith, S. A. et al. Polyphosphate modulates blood coagulation and fibrinolysis. Proc. Natl. Acad. Sci. USA 103, 903\u2013908 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"51745_CR28","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1055\/s-0037-1614171","volume":"84","author":"F Citarella","year":"2000","unstructured":"Citarella, F., te Velthuis, H., Helmer-Citterich, M. & Hack, C. E. Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII\u2013an immunochemical and homology modeling approach. Thrombosis Haemost. 84, 1057\u20131065 (2000).","journal-title":"Thrombosis Haemost."},{"key":"51745_CR29","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1055\/s-0036-1598003","volume":"43","author":"C Naudin","year":"2017","unstructured":"Naudin, C., Burillo, E., Blankenberg, S., Butler, L. & Renn\u00e9, T. Factor XII Contact Activation. Semin. Thrombosis Hemost. 43, 814\u2013826 (2017).","journal-title":"Semin. Thrombosis Hemost."},{"key":"51745_CR30","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1182\/blood.V99.10.3585","volume":"99","author":"F Mahdi","year":"2002","unstructured":"Mahdi, F., Madar, Z. S., Figueroa, C. D. & Schmaier, A. H. Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes. Blood 99, 3585\u20133596 (2002).","journal-title":"Blood"},{"key":"51745_CR31","doi-asserted-by":"crossref","unstructured":"Kaira, B. G., et al. Factor XII and kininogen asymmetric assembly with gC1qR\/C1QBP\/P32 is governed by allostery. Blood 136, 1685\u20131697 (2020).","DOI":"10.2210\/pdb6szw\/pdb"},{"key":"51745_CR32","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1055\/s-0039-3402760","volume":"120","author":"CC Clark","year":"2020","unstructured":"Clark, C. C. et al. The Fibronectin Type II Domain of Factor XII Ensures Zymogen Quiescence. Thrombosis Haemost. 120, 400\u2013411 (2020).","journal-title":"Thrombosis Haemost."},{"key":"51745_CR33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1074\/jbc.RA119.009788","volume":"295","author":"ZLM Hofman","year":"2020","unstructured":"Hofman, Z. L. M. et al. A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence, and accelerates activation. J. Biol. Chem. 295, 363\u2013374 (2020).","journal-title":"J. Biol. Chem."},{"key":"51745_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1055\/a-1951-1777","volume":"123","author":"R Frunt","year":"2023","unstructured":"Frunt, R., El Otmani, H., Gibril Kaira, B., de Maat, S. & Maas, C. Factor XII Explored with AlphaFold - Opportunities for Selective Drug Development. Thrombosis Haemost. 123, 177\u2013185 (2023).","journal-title":"Thrombosis Haemost."},{"key":"51745_CR35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.immuni.2011.02.008","volume":"34","author":"C Oschatz","year":"2011","unstructured":"Oschatz, C. et al. Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo. Immunity 34, 258\u2013268 (2011).","journal-title":"Immunity"},{"key":"51745_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(02)09743-X","volume":"360","author":"R Kahn","year":"2002","unstructured":"Kahn, R. et al. Contact-system activation in children with vasculitis. Lancet 360, 535\u2013541 (2002).","journal-title":"Lancet"},{"key":"51745_CR37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1681\/ASN.2019010032","volume":"31","author":"P Hu","year":"2020","unstructured":"Hu, P. et al. Kinin B1 Receptor Is Important in the Pathogenesis of Myeloperoxidase-Specific ANCA GN. J. Am. Soc. Nephrology 31, 297\u2013307 (2020).","journal-title":"J. Am. Soc. Nephrology"},{"key":"51745_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09492-4","volume":"10","author":"L Zhu","year":"2019","unstructured":"Zhu, L. et al. The cyclooxygenase-1\/mPGES-1\/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury. Nat. Commun. 10, 1888 (2019).","journal-title":"Nat. Commun."},{"key":"51745_CR39","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1161\/CIRCRESAHA.122.321365","volume":"131","author":"Q Wan","year":"2022","unstructured":"Wan, Q. et al. Targeting PDE4B (Phosphodiesterase-4 Subtype B) for Cardioprotection in Acute Myocardial Infarction via Neutrophils and Microcirculation. Circulation Res. 131, 442\u2013455 (2022).","journal-title":"Circulation Res."},{"key":"51745_CR40","doi-asserted-by":"publisher","first-page":"7471","DOI":"10.1021\/ac501202d","volume":"86","author":"X Liu","year":"2014","unstructured":"Liu, X. et al. VHH phage-based competitive real-time immuno-polymerase chain reaction for ultrasensitive detection of ochratoxin A in cereal. Anal. Chem. 86, 7471\u20137477 (2014).","journal-title":"Anal. Chem."},{"key":"51745_CR41","doi-asserted-by":"publisher","first-page":"e11349","DOI":"10.7554\/eLife.11349","volume":"4","author":"T Pleiner","year":"2015","unstructured":"Pleiner, T. et al. Nanobodies: site-specific labeling for super-resolution imaging, rapid epitope-mapping and native protein complex isolation. eLife 4, e11349 (2015).","journal-title":"eLife"},{"key":"51745_CR42","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1161\/ATVBAHA.117.309319","volume":"37","author":"G Aym\u00e9","year":"2017","unstructured":"Aym\u00e9, G. et al. A novel single-domain antibody against von Willebrand factor A1 domain resolves leukocyte recruitment and vascular leakage during inflammation\u2014brief report. Arteriosclerosis Thrombosis Vasc. Biol. 37, 1736\u20131740 (2017).","journal-title":"Arteriosclerosis Thrombosis Vasc. Biol."},{"key":"51745_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11255-0","volume":"10","author":"JD Ooi","year":"2019","unstructured":"Ooi, J. D. et al. A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity. Nat. Commun. 10, 3392 (2019).","journal-title":"Nat. Commun."},{"key":"51745_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1681\/ASN.2015121356","volume":"28","author":"J Chang","year":"2017","unstructured":"Chang, J. et al. CD8+ T cells effect glomerular injury in experimental anti-myeloperoxidase GN. J. Am. Soc. Nephrol. 28, 47\u201355 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"51745_CR45","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1681\/ASN.2014070673","volume":"26","author":"SV Kumar","year":"2015","unstructured":"Kumar, S. V. et al. Neutrophil extracellular trap-related extracellular histones cause vascular necrosis in severe GN. J. Am. Soc. Nephrol. 26, 2399\u20132413 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"51745_CR46","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1161\/ATVBAHA.118.310906","volume":"38","author":"S Zhu","year":"2018","unstructured":"Zhu, S., Chen, J. & Diamond, S. L. Establishing the transient mass balance of thrombosis: from tissue factor to thrombin to fibrin under venous flow. Arteriosclerosis Thrombosis Vasc. Biol. 38, 1528\u20131536 (2018).","journal-title":"Arteriosclerosis Thrombosis Vasc. Biol."},{"key":"51745_CR47","volume":"140","author":"N Madrahimov","year":"2018","unstructured":"Madrahimov, N. et al. Veno-venous extracorporeal membrane oxygenation in a mouse. J Vis Exp. 140, 58146 (2018).","journal-title":"J Vis Exp"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51745-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51745-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51745-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T10:40:57Z","timestamp":1726742457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51745-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["51745"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-51745-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"25 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.W. is a co-founder of NINGBO COMGEN BIOTECH CO., LTD. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7898"}}